147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
NORMAL SEARCH
ADVANCED SEARCH
More posts
BIO23131-T1

Lipc variant in the treatment of hypercholesterolemia and

Inventors have performed a pioneer study (Figure 5) by overexpressing control eGFP, human WT and E97G LIPC in full Ldlr-/- females fed with a […]

Read more

You might also be interested in

BIO22194-T1

Inhibitor of the heterochromatin protein 1 (hp1)

The present invention relates to a treatment of Th cell-associated disorders. Here, the
inventors […]

Read more
BIO23306-T1

Use of myeloperoxidase (mpo) inhibitors for

Host protection against infectious diseases involves complex cross-regulation between the immune […]

Read more
BIO21120-T1

Methods for the diagnosis and treatment of t

T-cell lymphomas are a heterogeneous group of malignancies involving T lymphocytes and generally […]

Read more
BIO21116-T1

Method to generate improving car-t cells

The present invention relates to the adoptive therapy using notably CAR-T cells. Here
the […]

Read more
BIO18552-T1

Mucosal-associated invariant t (mait) cells

The present invention relates generally to immunotherapy, in particular immunotherapy for treating […]

Read more
BIO20170-T1

Methods of treatment of iron overload associated

In the present invention, inventor identified the hepatokine FGL1 as a previously undescribed […]

Read more
BIO22566-T1

Methods of treating iron deficiency-related

Anemia, defined as a decreased quantity of circulating functional red blood cells, is a major source […]

Read more
BIO22467-T1

Gpr50 ligands for use for treating diseases

GPR50 (also known as MMR, H9 or ML1X), is an orphan G protein-coupled receptor
belonging to the […]

Read more
BIO21307-T1

Chronopharmacoligical use of dhodh inhibitor for

Targeting mitochondrial function is a strategy for preventing metabolic disorders, but restoring […]

Read more
BIO17543-T1

Use of retinoic acid receptor (rar) agonists

Aortic valve calcification is a condition in which calcium deposits form on the aortic valve in the […]

Read more
BIO22515-T1

Methods for the treatment of endometriosis

Endometriosis is a chronic oestrogen-dependent inflammatory disease characterised by the presence of […]

Read more
BIO22137-T1

Use of tryptophan hydroxylase 1 (tph1) inhibitors

Tryptophan (Trp) is one of the nine essential amino acids supplied by the diet, whose metabolism […]

Read more